| P53 pathway is a major determinant in the radiosensitizing effect of Palbociclib: Implication in cancer therapy DM Fernández-Aroca, O Roche, S Sabater, R Pascual-Serra, ... Cancer Letters 451, 23-33, 2019 | 54 | 2019 |
| p38MAPK and chemotherapy: we always need to hear both sides of the story J García-Cano, O Roche, FJ Cimas, R Pascual-Serra, M Ortega-Muelas, ... Frontiers in cell and developmental biology 4, 69, 2016 | 50 | 2016 |
| Exploiting the potential of autophagy in cisplatin therapy: A new strategy to overcome resistance J García-Cano, G Ambroise, R Pascual-Serra, MC Carrión, ... Oncotarget 6 (17), 15551, 2015 | 50 | 2015 |
| Autophagic cell death associated to Sorafenib in renal cell carcinoma is mediated through Akt inhibition in an ERK1/2 independent fashion L Serrano-Oviedo, M Ortega-Muelas, J Garcia-Cano, ML Valero, ... PLoS One 13 (7), e0200878, 2018 | 29 | 2018 |
| E1a is an exogenous in vivo tumour suppressor FJ Cimas, JL Callejas-Valera, DC García-Olmo, J Hernández-Losa, ... Cancer Letters 399, 74-81, 2017 | 15 | 2017 |
| MKP1 mediates chemosensitizer effects of E1a in response to cisplatin in non-small cell lung carcinoma cells FJ Cimas, JL Callejas-Valera, R Pascual-Serra, J García-Cano, ... Oncotarget 6 (42), 44095, 2015 | 13 | 2015 |
| p38β (MAPK11) mediates gemcitabine-associated radiosensitivity in sarcoma experimental models R Pascual-Serra, DM Fernández-Aroca, S Sabater, O Roche, I Andrés, ... Radiotherapy and Oncology 156, 136-144, 2021 | 9 | 2021 |
| ERK5 signalling pathway is a novel target of sorafenib: Implication in EGF biology M Ortega‐Muelas, O Roche, DM Fernández‐Aroca, JA Encinar, ... Journal of cellular and molecular medicine 25 (22), 10591-10603, 2021 | 5 | 2021 |
| p38MAPK and Chemotherapy: We Always Need to Hear Both Sides of the Story. Front Cell Dev Biol 2016; 4: 69 J García-Cano, O Roche, FJ Cimas, R Pascual-Serra, M Ortega-Muelas, ... | 5 | 2016 |
| Blockage of autophagic flux is associated with lymphocytosis and higher percentage of tumoral cells in chronic lymphocytic leukemia of B cells JR Romero-Macías, R Pascual-Serra, O Roche, F Ruiz-Marcos, ... Clinical and Translational Oncology 21, 1280-1285, 2019 | 3 | 2019 |
| ERK5 is a major determinant of chemical sarcomagenesis: Implications in human pathology E Arconada-Luque, J Jiménez-Suarez, R Pascual-Serra, SH Nam-Cha, ... Cancers 14 (14), 3509, 2022 | 2 | 2022 |
| p38ß (MAPK11) mediates gemcitabine-associated radiosensitivity in sarcoma experimental models R Pascual-Serra, DM Fernández-Aroca, S Sabater, O Roche, I Andrés, ... Elsevier, 2021 | | 2021 |
| Blockage of autophagic ux is associated with lymphocytosis and higher percentage of tumoral cells in chronic lymphocytic leukemia of B-cells O Roche, JR Romero-Macías, R Pascual-Serra, F Ruiz-Marcos, ... | | 2019 |
| Papel de la ruta de p38mapk en modelos de patología sarcomatoide: implicaciones en la biología tumoral y terapia RP Serra Universidad de Castilla-La Mancha, 2019 | | 2019 |
| Erk5 pathway is a new indirect target of sorafenib M Ortega-Muelas, L Muñoz-Martinez-Blanco, R Pascual-Serra, O Roche, ... | | 2018 |
| Palbociclib radiosensitizes colon and lung cancer cell lines in a p53-dependent manner DM Fernández-Aroca, O Roche, M Ortega-Muelas, R Pascual-Serra, ... | | 2018 |
